Health Trials

Posterior Capsule Opacification

2

Review clinical trials related to Posterior Capsule Opacification. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Clinical Evaluation of Low Contrast Visual Performance and Low Light Phenomena in Patients With Various Intraocular Lens Implants

The goal of this clinical investigation is to evaluate visual acuity and contrast sensitivity in low lighting conditions using several different testing devices, and measure nighttime side effects of intraocular lens (IOL) implants after cataract surgery. Researchers will compare the results for three different types of IOLs to see how each lens contributes to overall visual function, patient experience and satisfaction. Participants will: * Complete two different questionnaires about their current vision * Undergo visual testing using several different devices

Participants needed: 120
Trial details
Age: 22+Biological sex: AllType: ObservationalSponsor: Dr. Daniel H. Chang, MDUpdated: Apr 6, 2026Locations: 1Duration: 1 Day
Eligibility criteria

Minimum 22 years of age [+4]

Any clinically significant pupil abnormalities (non-reactive, fixed pupils, or a... [+5]

Read more
Status: Recruiting

IC-8 Apthera IOL New Enrollment Post Approval Study

The purpose of this study is to verify the post-market safety of the IC-8 Apthera IOL after the treatment of posterior capsular opacification (PCO), an expected complication related to IC-8 Apthera IOL implantation.

Participants needed: 435
Trial details
Age: 22+Biological sex: AllType: ObservationalSponsor: Bausch & Lomb IncorporatedUpdated: Jan 12, 2026Locations: 14
Eligibility criteria

22 years of age or older, any race and any gender; [+6]

Pharmacologically dilated pupil size less than 7.0 mm in the IC-8 Apthera IOL ey... [+11]

Read more